This article has been updated to include comments made by Luminex's management during a conference call.

NEW YORK (GenomeWeb) – Luminex reported after the close of the market on Thursday that its second quarter revenues rose 9 percent year over year, thanks in large part to a 37 percent increase in sales of its systems.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.